ÂÜÀòÂÒÂ×

Caitlin Cutter is a seasoned professional with extensive experience in the biopharmaceutical industry. Currently serving as Director of MSAT at Ultragenyx since March 2023, Caitlin has held significant roles including Head of Process Validation at Thermo Fisher Scientific from January 2022 to March 2023 and Principal Validation Engineer at Alnylam Pharmaceuticals from September 2017 to January 2022. Previous positions include Senior Validation Engineer, Manufacturing Technology Engineer at Bristol-Myers Squibb, and Process Engineer II at Genzyme. Educational credentials include a Master of Science in Engineering Management from Tufts University and a Bachelor of Science in Chemical Engineering from Cornell University.